Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy

Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy

Abstract Background & aims This study aims to assess the nutritional status of patients during the different phases of the Chimeric Antigen Receptor (CAR)-T cell therapy and to identify prominent risk factors of hypoalbuminemia in patients after CAR-T treatment. The clinical consequences of maln...

Full description

Bibliographic Details
Main Authors: Shuyi Ding, Rongrong Chen, Linqin Wang, Cheng Zu, Xiaoyu Zhou, Jianli Zhang, Mingming Zhang, Aiyun Jin, Tingting Wang, Yongxian Hu
Format: Article
Language:English
Published: BMC 2023-11-01
Series:BMC Cancer
Subjects:
Chimeric Antigen Receptor (CAR)-T cell therapy
Cytokine release syndrome
Hypoalbuminemia
Hematological malignancies
Online Access:https://doi.org/10.1186/s12885-023-11540-8

Internet

https://doi.org/10.1186/s12885-023-11540-8

Similar Items